dimaprit has been researched along with Bleeding in 2 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study aimed to compare the impact of clopidogrel with ticagrelor on clinical outcomes in East Asian patients aged ≥75 years with acute coronary syndrome (ACS) using data from an institutional registry." | 8.12 | Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry. ( Gao, R; Gao, Y; Guo, T; Li, J; Qiu, H; Qiu, Z; Wang, Y; Xi, Z; Zheng, J, 2022) |
| " This study aimed to compare the impact of clopidogrel with ticagrelor on clinical outcomes in East Asian patients aged ≥75 years with acute coronary syndrome (ACS) using data from an institutional registry." | 4.12 | Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry. ( Gao, R; Gao, Y; Guo, T; Li, J; Qiu, H; Qiu, Z; Wang, Y; Xi, Z; Zheng, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xi, Z | 1 |
| Qiu, Z | 1 |
| Li, J | 1 |
| Qiu, H | 1 |
| Guo, T | 1 |
| Wang, Y | 1 |
| Zheng, J | 1 |
| Gao, Y | 1 |
| Gao, R | 1 |
| Smits, PC | 1 |
| Frigoli, E | 1 |
| Vranckx, P | 1 |
| Ozaki, Y | 1 |
| Morice, MC | 1 |
| Chevalier, B | 1 |
| Onuma, Y | 1 |
| Windecker, S | 1 |
| Tonino, PAL | 1 |
| Roffi, M | 1 |
| Lesiak, M | 1 |
| Mahfoud, F | 1 |
| Bartunek, J | 1 |
| Hildick-Smith, D | 1 |
| Colombo, A | 1 |
| Stankovic, G | 1 |
| Iñiguez, A | 1 |
| Schultz, C | 1 |
| Kornowski, R | 1 |
| Ong, PJL | 1 |
| Alasnag, M | 1 |
| Rodriguez, AE | 1 |
| Paradies, V | 1 |
| Kala, P | 1 |
| Kedev, S | 1 |
| Al Mafragi, A | 1 |
| Dewilde, W | 1 |
| Heg, D | 1 |
| Valgimigli, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen[NCT03023020] | 4,579 participants (Actual) | Interventional | 2017-04-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dimaprit and Bleeding
| Article | Year |
|---|---|
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
Topics: Anticoagulants; Dimaprit; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Perc | 2022 |
1 other study available for dimaprit and Bleeding
| Article | Year |
|---|---|
Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Dimaprit; Fibrinolytic Agents; Hemorrhage; Humans; Percu | 2022 |